The website sucks, the revenues are non-existent, but since they filed for the first time since 2011 to get current, the penny stock of OpenCell Biomed, Inc. (OCBM) is suddenly a target for traders. With a float of just above 6 million and a current share price which $5K could consume about 25% of the float, OCBM stock is looking a lot stronger than the titanium foam coated ...
8
JAN
JAN
0
Share
